ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 617

$523K Total Retail Price of All Prescriptions

Rank: 87 out of 617

270 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 270 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 270 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 8,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
DONEPEZIL HCL 429 429 1 30
NAMENDA 414 414 2 35
METOPROLOL TARTRATE 406 366 3 11
LEVOTHYROXINE SODIUM 396 370 4 1
FUROSEMIDE 303 263 5 4
WARFARIN SODIUM 276 194 6 7
LISINOPRIL 253 238 7 5
OMEPRAZOLE 232 222 8 3
HYDROCODONE-ACETAMINOPHEN 207 187 S3 9 8
SIMVASTATIN 206 176 10 2
GABAPENTIN 203 153 11 16
MIRTAZAPINE 195 195 12 50
POLYETHYLENE GLYCOL 3350 157 156 13 32
SERTRALINE HCL 154 146 14 20
TRAZODONE HCL 153 143 15 51
AMLODIPINE BESYLATE 141 139 16 6
TAMSULOSIN HCL 132 110 17 26
PREDNISONE 129 110 18 31
CITALOPRAM HBR 122 106 19 18
CYMBALTA 115 86 20 49
OXYCODONE HCL 114 68 S2 21 130
METOPROLOL SUCCINATE 107 105 22 12
ATENOLOL 102 97 23 17
ALENDRONATE SODIUM 94 82 24 25
OXYCODONE-ACETAMINOPHEN 93 20 S2 25 93
OXYCONTIN 83 43 S2 26 133
LIDODERM 82 76 27 188
QUETIAPINE FUMARATE 81 74 28 78
NEXIUM 78 60 29 43
ZOLPIDEM TARTRATE 76 66 30 23
KLOR-CON M20 73 66 31 116
LYRICA 71 43 32 92
MORPHINE SULFATE ER 68 51 S2 33 128
TRAMADOL HCL 66 43 34 15
ADVAIR DISKUS 64 64 35 38
OXYBUTYNIN CHLORIDE ER 63 61 36 114
ATORVASTATIN CALCIUM 63 50 36 14
LEVETIRACETAM 63 53 36 166
FENTANYL 61 53 S2 39 45
DIGOXIN 58 57 40 48
NYSTOP 58 43 40 220
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 47 42 91
LOSARTAN POTASSIUM 57 51 42 22
FINASTERIDE 54 38 44 104
HYDROCHLOROTHIAZIDE 54 41 44 13
METFORMIN HCL 53 53 46 9
DIVALPROEX SODIUM ER 53 51 46 181
CARVEDILOL 53 40 46 19
LANTUS 52 42 49 39
POTASSIUM CHLORIDE 50 40 50 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.